BSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarti Drugs Ltd: key numbers
- Share price
- ₹435.20
- Market cap
- ₹3,972 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 20.8×Sector 45.9×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Drugs Ltd
All →Aarti Drugs Board Meeting Date
Aarti Drugs Ltd intimated BSE and NSE of a board meeting on November 3, 2026, to consider audited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results declaration.
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Aarti Drugs Other Announcement
Aarti Drugs has updated its list of authorized personnel for determining materiality of events and making stock exchange disclosures, effective October 1, 2026.
Aarti Drugs Management Change
Aarti Drugs Ltd announced the retirement of Director Uday M. Patil and the appointment of new directors, including Adhish P. Patil as the Managing Director.
Aarti Drugs Investor Presentation: Key Takeaways
Aarti Drugs reports Q1 FY27 revenue of ₹704 Cr, up 19% YoY. Management focuses on scaling regulated market sales through high-margin formulations and oncology backward integration.
Aarti Drugs Annual General Meeting
Aarti Drugs Limited conducted its 41st Annual General Meeting on September 26, 2026, to consider various ordinary and special business resolutions.
Other annual report announcements
All →Garment Mantra Lifestyle Annual Report
Garment Mantra Lifestyle submitted a revised FY2025-26 Annual Report correcting five observations, including related-party transaction labels and auditor location. No financial event or new business activity is reported.
Inani Securities Annual Report
Inani Securities submitted its 32nd Annual Report for FY 2025-26 with the AGM notice, AGM set for 23 September 2026. The filing is the full annual report and cover letter.
Datakosa Annual Report
Bodhtree Consulting filed its 44th Annual Report for FY 2025-26 with the AGM notice for September 9, 2026. It reports no new transaction or financial event.
Morarka Finance Annual Report
Morarka Finance filed its 2025-26 Annual Report and AGM notice for the July 15, 2026 meeting. Agenda includes Pranay Morarka's Managing Director appointment and remuneration.
Venlon Enterprises Annual Report
Venlon Enterprises filed its 2025-26 Annual Report ahead of its September 18, 2026 AGM. The notice seeks approval for three related-party transactions.
Gujarat Peanut and Agri Products Annual Report
Gujarat Peanut And Agri Products filed a resubmitted Annual Report for FY 2025-26 after an earlier filing went under the wrong module. The report shows turnover of Rs. 38,932.71 Lakhs and PAT of Rs. 738.30 Lakhs.